Actively Recruiting
[18F]FES PET/CT for the Detection of Distant Metastasis in Low-grade ER-positive Stage III Breast Cancer
Led by Asan Medical Center · Updated on 2026-01-02
85
Participants Needed
1
Research Sites
209 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study aims to evaluate the detection rate of distant metastases using \[18F\]FES PET/CT in patients with low-grade, ER-positive stage III breast cancer.
CONDITIONS
Official Title
[18F]FES PET/CT for the Detection of Distant Metastasis in Low-grade ER-positive Stage III Breast Cancer
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Male or female patients aged 19 years or older
- Newly diagnosed with invasive breast cancer within 90 days before screening, confirmed by histopathology
- Histologically confirmed estrogen receptor-positive, histologic grade 1 or 2 primary breast cancer
- Clinical stage IIIA to IIIC breast cancer according to AJCC 8th edition
- Completed or scheduled chest CT, abdominal CT, and bone scintigraphy within 90 days before screening
- Eastern Cooperative Oncology Group performance status score of 0 to 2
You will not qualify if you...
- Not having signed informed consent
- Currently receiving systemic therapy for breast cancer (e.g., chemotherapy, hormonal therapy)
- History of another invasive cancer within the past 2 years (except non-melanoma skin cancer)
- Diagnosed with distant metastases on recent chest CT, abdominal CT, or bone scans within 90 days prior to screening
- No biopsy or at least 6 months of follow-up imaging for suspicious lesions
- Pregnant or breastfeeding women, except those postmenopausal, surgically sterile, or with a negative pregnancy test and using contraception
- Serious or uncontrolled medical conditions such as heart failure, recent heart attack, severe lung, kidney, or liver disease
- Relatives or students of the investigator or in dependent relationships
- Unable to provide complete clinical trial data due to personal circumstances or other reasons
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Asan Medical Center
Seoul, South Korea
Actively Recruiting
Research Team
S
Sangwon Han
CONTACT
J
Jaeeun Kim
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
DIAGNOSTIC
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here